Centro de Reumatologia y Ortopedia SAS

Barranquilla 80020

0 studies enrolling now · 5 studies all time

What they study most

Fibrosis, Idiopathic Interstitial Pneumonias, Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, Pathologic Processes, Respiratory Tract Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus

Studies at this site

• Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis — Completed
• Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease — Completed
• A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis — Stopped early
• A Phase II Study of M2951 in SLE — Stopped early
• Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis — Completed